Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Converting enzyme inhibitors in hypertension and heart failure.

× No keyword cloud information.

24 in total

1. Distribution of endogenous cobalamin between the transcobalamins in various mammals.

Authors: J C Linnell; L Collings; M C Down; J M England
Journal: Clin Sci (Lond) Date: 1979-08 Impact factor: 6.124

2. Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients.

Authors: D B Case; S A Atlas; J H Laragh; J E Sealey; P A Sullivan; D N McKinstry
Journal: Prog Cardiovasc Dis Date: 1978 Nov-Dec Impact factor: 8.194

Review 3. Captopril in the treatment of clinical hypertension and cardiac failure.

Authors: A B Atkinson; J I Robertson
Journal: Lancet Date: 1979-10-20 Impact factor: 79.321

4. The intramedullary connections of the area postrema involved in the central cardiovascular response to angiotensin II.

Authors: M D Joy
Journal: Clin Sci Date: 1971-08 Impact factor: 6.124

5. Relationship of plasma volume changes to resistance and capacitance vessel effects of sympathomimetic amines and angiotensin in man.

Authors: J N Cohn
Journal: Clin Sci Date: 1966-04 Impact factor: 6.124

6. Renin relationships in congestive cardiac failure, treated and untreated.

Authors: J J Brown; D L Davies; V W Johnson; A F Lever; J I Robertson
Journal: Am Heart J Date: 1970-09 Impact factor: 4.749

7. The role of angiotensin in the control of blood pressure during sodium depletion.

Authors: J Conway; R Hatton; J Keddie; P Dawes
Journal: Hypertension Date: 1979 Jul-Aug Impact factor: 10.190

8. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.

Authors: R Ader; K Chatterjee; T Ports; B Brundage; B Hiramatsu; W Parmley
Journal: Circulation Date: 1980-05 Impact factor: 29.690

9. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

Authors: M A Ondetti; B Rubin; D W Cushman
Journal: Science Date: 1977-04-22 Impact factor: 47.728

10. Improvement of chronic congestive heart-failure by oral captopril.

Authors: G A Turini; H R Brunner; M Gribic; B Waeber; H Gavras
Journal: Lancet Date: 1979-06-09 Impact factor: 79.321

7 in total

1. Plasma free captopril concentrations during short and long term treatment with oral captopril for heart failure.

Authors: T R Shaw; F M Duncan; B C Williams; E Crichton; S A Thomson; J R Davis; M Rademaker; C R Edwards
Journal: Br Heart J Date: 1985-08

2. Influence of a single dose of captopril on pulmonary haemodynamics and right ventricular function in mitral stenosis with pulmonary hypertension.

Authors: K Zmudka; J P Dubiel; T Brzostek; T Horzela
Journal: Eur J Clin Pharmacol Date: 1988 Impact factor: 2.953

3. Captopril: five years on.

Authors: G P Hodsman; J I Robertson
Journal: Br Med J (Clin Res Ed) Date: 1983-09-24

4. Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man.

Authors: G P Hodsman; J R Zabludowski; C Zoccali; R Fraser; J J Morton; G D Murray; J I Robertson
Journal: Br J Clin Pharmacol Date: 1984-03 Impact factor: 4.335

5. Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy.

Authors: P G Agostoni; N De Cesare; E Doria; A Polese; G Tamborini; M D Guazzi
Journal: Br Heart J Date: 1986-04

6. Captopril: 4 years of post marketing surveillance of all patients in New Zealand.

Authors: I R Edwards; D M Coulter; D M Beasley; D MacIntosh
Journal: Br J Clin Pharmacol Date: 1987-05 Impact factor: 4.335

7. A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man.

Authors: P J Manhem; S G Ball; J J Morton; G D Murray; B J Leckie; R Fraser; J I Robertson
Journal: Br J Clin Pharmacol Date: 1985-07 Impact factor: 4.335

7 in total